European journal of endocrinology
-
Eur. J. Endocrinol. · Mar 2021
Observational StudyPrevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.
The pandemic of coronavirus disease (COVID-19) has rapidly spread globally and infected millions of people. The prevalence and prognostic impact of dysnatremia in COVID-19 is inconclusive. Therefore, we investigated the prevalence and outcome of dysnatremia in COVID-19. ⋯ Our results underline the importance of dysnatremia as predictive marker in COVID-19. Treating physicians should be aware of appropriate treatment measures to be taken for patients with COVID-19 and dysnatremia.